Drosos Karageorgopoulos, MD, PhD, MPH
Drosos Karageorgopoulos, MD, PhD, MPH
Oxford University Hospitals NHS Foundation Trust
Verified email at
Cited by
Cited by
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections
DE Karageorgopoulos, ME Falagas
The Lancet infectious diseases 8 (12), 751-762, 2008
Comparison of SCImago journal rank indicator with journal impact factor
ME Falagas, VD Kouranos, R Arencibia-Jorge, DE Karageorgopoulos
The FASEB journal 22 (8), 2623-2628, 2008
Extended-spectrum β-lactamase-producing organisms
ME Falagas, DE Karageorgopoulos
Journal of Hospital infection 73 (4), 345-354, 2009
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review
ME Falagas, AC Kastoris, AM Kapaskelis, DE Karageorgopoulos
The Lancet infectious diseases 10 (1), 43-50, 2010
β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis
DE Karageorgopoulos, EK Vouloumanou, F Ntziora, A Michalopoulos, ...
Clinical Infectious Diseases 52 (6), 750-770, 2011
Deaths attributable to carbapenem-resistant Enterobacteriaceae infections
ME Falagas, GS Tansarli, DE Karageorgopoulos, KZ Vardakas
Emerging infectious diseases 20 (7), 1170, 2014
Etiology of anemia in patients with advanced heart failure
JN Nanas, C Matsouka, D Karageorgopoulos, A Leonti, E Tsolakis, ...
Journal of the American College of Cardiology 48 (12), 2485-2489, 2006
Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology
ME Falagas, DE Karageorgopoulos
Clinical infectious diseases 46 (7), 1121-1122, 2008
Late Ebola virus relapse causing meningoencephalitis: a case report
M Jacobs, A Rodger, DJ Bell, S Bhagani, I Cropley, A Filipe, RJ Gifford, ...
The Lancet 388 (10043), 498-503, 2016
Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
ME Falagas, PI Rafailidis, E Ioannidou, VG Alexiou, DK Matthaiou, ...
International journal of antimicrobial agents 35 (2), 194-199, 2010
Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis
EK Vouloumanou, E Plessa, DE Karageorgopoulos, E Mantadakis, ...
Intensive care medicine 37, 747-762, 2011
Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens
DE Karageorgopoulos, R Wang, X Yu, ME Falagas
Journal of Antimicrobial Chemotherapy 67 (2), 255-268, 2012
Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence
DE Karageorgopoulos, T Kelesidis, I Kelesidis, ME Falagas
Journal of Antimicrobial Chemotherapy 62 (1), 45-55, 2008
Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies
T Kelesidis, DE Karageorgopoulos, I Kelesidis, ME Falagas
Journal of antimicrobial chemotherapy 62 (5), 895-904, 2008
MRSA in Africa: filling the global map of antimicrobial resistance
ME Falagas, DE Karageorgopoulos, J Leptidis, IP Korbila
PloS one 8 (7), e68024, 2013
Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies
ME Falagas, AC Kastoris, DE Karageorgopoulos, PI Rafailidis
International journal of antimicrobial agents 34 (2), 111-120, 2009
Accuracy of β-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis
DE Karageorgopoulos, JM Qu, IP Korbila, YG Zhu, VA Vasileiou, ...
Clinical Microbiology and Infection 19 (1), 39-49, 2013
Short-versus long-course antibacterial therapy for community-acquired pneumonia: a meta-analysis
G Dimopoulos, DK Matthaiou, DE Karageorgopoulos, AP Grammatikos, ...
Drugs 68, 1841-1854, 2008
Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin
ME Falagas, S Maraki, DE Karageorgopoulos, AC Kastoris, ...
International journal of antimicrobial agents 35 (3), 240-243, 2010
Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes
ME Falagas, DE Karageorgopoulos, P Nordmann
Future microbiology 6 (6), 653-666, 2011
The system can't perform the operation now. Try again later.
Articles 1–20